Features of correction of a pathological condition of small animals at the diabetes mellitus with obesity
The article presents the results of clinical studies of domestic cats and dogs with diabetes mellitus on the background of obesity at the beginning and for a month of treatment. Domestic cats with diabetes were prescribed active exercise and industrial diet Royal Canin Diabetic Feline, dogs – Royal Canin Diabetic DS37. The portion size was determined according to the manufacturer's recommendations. Treatment of small animals for obesity, both alimentary and endocrine, preferably involves feeding food in limited quantities to cause controlled weight loss, as well as increased physical activity, which can provide additional energy expenditure. Successful weight loss can reduce the effects of comorbidities associated with obesity, such as improved mobility in osteoarthritis, increased insulin sensitivity and the reversal of other metabolic disorders, and improved quality of life. The main pathogenetic therapy for animals with diabetes for both domestic cats and dogs is the mandatory use of insulin. Researching the market of drugs in Ukraine, we chose the most affordable and effective veterinary drug – Caninsulin. The dose of insulin was selected individually for each animal by plotting a curve of blood glucose concentration over three days. At the beginning of treatment and at the end of the course, we conducted a comprehensive study of animals of both species. In cats, the general condition significantly improved as a result of treatment: only one animal remained depressed, the number of cases of hyporexia decreased, only 25.0 % of animals remained pale mucous membranes; temperature within the physiological norm; vomiting and bradycardia were not reported. A decrease in the rate of shortness of breath and drowsiness also indicates an improvement in the condition of cats with obesity due to diabetes. The improvement of the general condition of domestic dogs is evidenced by the restoration of the condition of the coat (about 4 times), the restoration of appetite in 66.7 %. Only one dog had anemia of the mucous membranes. Anxiety, bradycardia, hypothermia and itching disappeared completely. Within one month, there was a tendency to decrease the body weight of animals of both groups, but due to the insufficient duration of treatment, their fatness still remained excessive. Which indicates the need for further correction of the pathological condition.
Christmann, U., Becvarova, I., Were, S. R., & Meyer, H. P. (2015). Effectiveness of a new dietetic weight management food to achieve weight loss in client-owned obese cats. J Fel Med Surg, 18, 947–953. doi: 10.1177/1098612X15599823
Flanagan, J., Bissot, T., Hours, M.-A., Moreno, B., Feugier, A., & German, A. J. (2017). Success of a weight loss plan for overweight dogs: The results of an international weight loss study. PLoS ONE, 12. doi: 10.1371/journal.pone.0184199.
German, A. J., Hervera, M., Hunter, L., Holden, S. L., Morris, P. J., Biourge, V. et al. (2009). Insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrin, 37(4), 214–226. doi: 10.1016/j.domaniend.2009.07.001.
German, A. J., Holden, S. L., Bissot, T., Hackett, R. M., & Biourge, V. (2007). Dietary energy restriction and successful weight loss in obese client-owned dogs. J Vet Intern Med, 21(6), 1174–1180. doi: 10.1892/06-280.1.
German, A. J., Holden, S. L., Bissot, T., Morris, P. J., & Biourge, V. (2008). Changes in body composition during weight loss in obese client-owned cats: loss of lean tissue mass correlates with overall percentage of weight lost. J Fel Med Surg, 10, 452–459. doi: 10.1016/j.jfms.2008.02.004.
German, A. J., Holden, S. L., Bissot, T., Sergheraert, R., Biourge, V., & German, A. J. (2010). A high protein high fibre diet improves weight loss in obese dogs. Vet J, 183, 294–297. doi: 10.1016/j.tvjl.2008.12.004.
German, A. J., Holden, S. L., Wiseman-Orr, M. L., Reid, J., Nolan, A. M., Biourge, V. et al. (2012). Quality of life is reduced in obese dogs but improves after successful weight loss. Vet J, 192(3), 428–434. doi: 10.1016/j.tvjl.2011.09.015.
German, A. J., Titcomb, J. M., Holden, S. L., Queau, Y., Morris, P. J., & Biourge, V. (2015). Cohort study of the success of controlled weight loss programs for obese dogs. J Vet Intern Med. 29(6), 1547–1555. doi: 10.1111/jvim.13629.
Lokes-Krupka, T. P. (2019). Klinichnyy vypadok alimentarnoho ozhyrinnya u sobaky. Visnyk PDAA, 2, 213–218. doi: 10.31210/visnyk2019.02.28 (in Ukrainian).
Lokes-Krupka, T. P., & Tsvilikhovsʹkyy, M. I. (2019). Klinichni ta morfometrychni pokaznyky u sviysʹkykh kota i sobaky za nayavnosti ozhyrinnya, shcho zumovleno tsukrovym diabetom. Visnyk PDAA, 3, 221–227. doi: 10.31210/visnyk2019.03.30 (in Ukrainian).
Marshall, W. G., Hazelwinkel, H. A. W., Mullen, D. et al. (2010). The effect of weight loss on lameness in obese dogs with osteoarthritis. Vet Res Comm, 34(3), 241–253. doi: 10.1007%2Fs11259-010-9348-7.
McCann, T. M., Simpson, K. E., Shaw D. J. et al. (2007). Feline diabetes mellitus in the UK: the prevalence within an insured cat population and a questionnairebased putative risk factor analysis. J Feline Med Surg, 9(4), 289–299. doi: 10.1016/j.jfms.2007.02.001.
Morozenko, D. V., Timoshenko, O. P., & Vodop'yanova, L. A. (2010). Gistologicheskaya kartina podzheludochnoyzhelezy i biokhimicheskiye kriterii diagnostiki pri sakharnomdiabete u domashnikh koshek. Vísnyk PDAA, 3, 122–124. URL: https://www.pdaa.edu.ua/sites/default/files/visnyk/2010/03/122_124.pdf (in Russian).
Ou, X. H., Zhu, C. C., & Sun, S. C. (2018). Effects of obesity and diabetes on the epigenetic modification of mammalian gametes. J Cell Physiol, 234(6), 7847–7855. doi: 10.1002/jcp.27847.
Owens, T. J., Larsen, J. A., Farcas, A. K., Nelson, R. W., Kass, P. H., & Fascetti, A. J. (2014). Total dietary fiber composition of diets used for management of obesity and diabetes mellitus in cats. J Am Vet Med Assoc, 245(1), 99–105. doi: 10.2460/javma.245.1.99.
Scuderi, M. A., Ribeiro Petito, M., Unniappan, S., Waldner, C., Mehain, S., McMillian, C. J., & Snead, E. C. (2018). Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus. Domest Anim Endocrinol, 65, 80–89. doi: 10.1016/j.domaniend.2018.04.003.
Tvarijonaviciute, A., Ceron, J. J., Holden, S. L., Biourge, V., Morris, P. J., & German, A. J. (2012). Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome. BMC Vet Res, 8, 147 doi: 10.1186/1746-6148-8-147.
Vitger, A. D., Stallknecht, B. M., Nielsen, D. H., & Bjornvad, C. R. (2016). Integration of a physical training program in a weight loss plan for overweight pet dogs. J Am Vet Med Assoc, 248(2), 174–182. doi: 10.2460/javma.248.2.174.
Yaissle, J. E., Holloway, C., & Buffington, C. A. (2004). Evaluation of owner education as a component of obesity treatment programs for dogs. J Am Vet Med Assoc, 224(12), 1932–1935. doi: 10.2460/javma.2004.224.1932.
Zimin, N. L. (2005). Endokrinologiya v prakticheskoy veterinarii. Veterinarnyy konsul'tant, 17, 10–15 (in Russian).
Zoran, D. L. (2010). Obesity in dogs and cats: a metabolic and endocrine disorder. Vet Clin North Am Small Anim Pract, 40(2), 221–239. doi: 10.1016/j.cvsm.2009.10.009.
Abstract views: 8 PDF Downloads: 8